Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1081–1104 of 1,393 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Emergency Room Clear all

Conditions: Gastroenteritis
Interventions: LGG, micro-crystalline cellulose; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 3 Months to 48 Months
Enrollment: 971 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 10
States / cities: Sacramento, California • Washington D.C., District of Columbia • Chicago, Illinois + 7 more

Conditions: Alcohol Dependency
Interventions: SBIRT; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years and older
Enrollment: 791 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: San Diego, California

Conditions: Fatigue, Sleep
Interventions: SaFTiE, Attention Placebo Control; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 708 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Psychosis, Agitation, Delirium
Interventions: ziprasidone, Standard therapy; Drug
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Supraventricular Tachycardia (SVT)
Interventions: adenosine, diltiazem; Drug
Lead sponsor: Anne E. Zepeski; Other
Eligibility: 18 Years to 100 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Drug Abuse
Interventions: Computer-delivered Brief Intervention (CBI), Intervener-delivered Brief Intervention (IBI), Adapted Motivational Enhancement Therapy (AMET), Enhanced Usual Care (EUC); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 60 Years
Enrollment: 878 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: Treatment as Usual, Family Navigator
Interventions: Treatment as usual, Family Navigator; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 10 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Patient Satisfaction With Emergency Department Efficiency
Interventions: Physician at triage, Usual Care; Behavioral · Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 110 Years
Enrollment: 439 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Out-Of-Hospital Cardiac Arrest
Interventions: igel, Compression Rate; Device · Procedure
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 4,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Pain
Interventions: Hydromorphone; Drug
Lead sponsor: Columbia University; Other
Eligibility: 4 Years to 17 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Nephrolithiasis, Ureteral Calculi
Interventions: tamsulosin, Standard therapy with ibuprofen and oxycodone.; Drug
Lead sponsor: MaineHealth; Other
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Portland, Maine

Conditions: HIV Counseling and Testing, HIV Infections
Interventions: HIV educational video; Procedure
Lead sponsor: North Bronx Healthcare Network; Other
Eligibility: 18 Years and older
Enrollment: 408 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: COPD Exacerbation
Interventions: Revefenacin, formoterol fumarate, Placebo (Sterile Normal Saline), Albuterol sulfate, Ipratropium Bromide; Drug · Other
Lead sponsor: University of Tennessee Graduate School of Medicine; Other
Eligibility: 40 Years and older
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Healthy Volunteers
Interventions: Not listed
Lead sponsor: Corewell Health South; Other
Eligibility: 18 Years and older
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Saint Joseph, Michigan

Conditions: Delirium
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: 65 Years and older
Enrollment: 228 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Congestive Heart Failure, Metastatic Cancer, Chronic Kidney Disease Requiring Chronic Dialysis, Chronic Obstructive Pulmonary Disease
Interventions: ED GOAL; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiac Arrest, Pulseless Electrical Activity
Interventions: High Calcium, Low Sodium (HCLS) Crystalloid Therapy, High Calcium, High Sodium (HCHS) Crystalloid Therapy; Drug
Lead sponsor: Carol Bernier; Other
Eligibility: 18 Years and older
Enrollment: 342 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Benign Headache
Interventions: 0.5% bupivacaine, Standard Care; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Radicular Low Back Pain
Interventions: Intramuscular methylprednisolone acetate, Placebo; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 21 Years to 50 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Contraception Behavior
Interventions: Education Arm; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 15 Years to 21 Years · Male only
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Syncope, Presyncope
Interventions: Not listed
Lead sponsor: Columbia University; Other
Eligibility: 40 Years and older
Enrollment: 1,297 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 5
States / cities: Sacramento, California • New York, New York • Rochester, New York + 1 more

Conditions: Parents, Self Efficacy, Mental Health Literacy, Psychiatric Emergency
Interventions: iPEACE: Intervention for Parent Education about Care after the ED, Text Messaging Reminders Only; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), Hyperglycemia, Insulin Dependent Diabetes
Interventions: Hemoglobin A1c, Observation Unit; Diagnostic Test · Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 21 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Intubation
Interventions: Apneic oxygenation, Pre-oxgenation with NRB, NIPPV, BVM; Other
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Murray, Utah

Search by objective public record fields.

Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis

Alcohol Screening, Brief Intervention, and Referral to Treatment in a Military Treatment Facility

The Sleep and Teamwork in EMS Study

Ziprasidone vs Standard Therapy for Agitated Patients in the ED

Adenosine vs Diltiazem for Treatment of SVT in the ED

Healthier You: Optimizing Screening, Brief Interventions, and Referral to Treatment (SBIRT) in the Emergency Department

Family Navigator Intervention

Role of Provider-at-Triage on ED Efficiency and Quality of Care

First Responder Airway & Compression Rate Trial

Intranasal Hydromorphone for the Treatment of Acute Pain in Children: A Pilot Study.

The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients

An Effective Alternative to the Standard Referral System for HIV Testing in the Emergency Department During Off Hour Tours: A Randomized Trial

Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)

Ultrasound to View Abdominal Wall Muscle Layers

Delirium in the Emergency Department and Its Extension Into Hospitalization

Advance Care Planning in the Emergency Department

Surviving PEA in Roanoke (SPEAR) Study

Bupivacaine for Benign Headache in the ED

A Trial of Corticosteroids for Low Back Pain

Hormonal Contraceptive Health Education for Adolescent Males

Practical Approaches to Care in Emergency Syncope

Text-messaging Intervention to Support Parents After Their Child's Psychiatric Emergency

Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED

Utah Study Evaluating Apneic Oxygenation for Emergency Department Intubation